CB1 Capital Management predicts Cannabis could disrupt the healthcare industry in a big way. The firm's Founding Partner and Chief Investment Officer Todd Harrison explains why he thinks medical marijuana will migrate from state dispensaries, to become medicine prescribed by doctors through insurance in the next decade.
Harrison says the only way the U.S. government would get their hands on the money in this market opportunity is through the FDA. "That's where we think it goes, follow the money," says Harrison.
"This is not so much a trade about commerce, as it is a trade about healthcare," said Harrison. "We think that this is going to migrate towards medicine." One of CB1 Capital Management's holdings GW Pharmaceuticals is up 30 percent over the past three months. Harrison expects this company to publish research showing the efficacy of cannabis treatment this summer.
Many people are thinking of their New Year's resolutions and resetting goals. Phyllis Ehrlich, career coach and president of Rocket Your Potential, joined Cheddar News to provide tips on how to polish up your resume for 2024 and explain why you should.
A 6-year-old boy who left on a flight for the Christmas holiday to visit his grandmother in southwest Florida instead was put on the wrong plane and ended up 160 miles away in Orlando, Florida.
Apple filed an emergency motion seeking court permission to begin selling two of its most popular watches again until a final decision on its broader appeal in a bitter patent dispute is decided.
